AstraZeneca Research Facilities - Wilmington, US

Go to navigation
Go to content

R&D Wilmington is located in Wilmington, Delaware, not far from Philadelphia. Research here is focused on pain control, neurology and psychiatry. The site is a centre of excellence in psychiatry, concentrating on developing therapies for schizophrenia, anxiety, depression, bipolar and dementia.

We employ over 2,000 people in R&D in Wilmington, which is also our US Corporate HQ with over 5,000 employees in total.

Not signed in

Page tools

Share price

London: 26.95 GBP
New York: 44.82 USD
Stockholm: 310.10 SEK

At 21-Nov-2009 03:08 GMT

Detailed share price

Introduction to AstraZeneca

Our responsibility

We continue to communicate openly on a range of issues, including:

Did you know

Contact us

Email enquiry form

This website is intended for people seeking information on the AstraZeneca International business. If you are in the US you should visit AstraZeneca US.

We also have national business sites which can be found under our list of AstraZeneca websites.

We also have specific national and international websites designed for patients and healthcare professionals. If you have a question you can contact us.